<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
36998-6000-0
</NDCCode>
<PackageDescription>
5000 mL in 1 BAG (36998-6000-0)
</PackageDescription>
<NDC11Code>
36998-6000-00
</NDC11Code>
<ProductNDC>
36998-6000
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Bimekizumab
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20231017
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
UCB Pharma S.A.
</LabelerName>
<SubstanceName>
BIMEKIZUMAB
</SubstanceName>
<StrengthNumber>
160
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2026-01-01
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
01-JAN-26
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>